G. Hecker

发表

Platelet-Neutrophil Interactions

V. Ullrich, G. Hecker, M. Schatz-Munding, 1991 .

Low levels of hydrogen peroxide enhance platelet aggregation by cyclooxygenase activation.

V. Ullrich, G. Hecker, J. Utz, 1991, Eicosanoids.

Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2

K. Schrör, P. Ney, G. Hecker, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Different Effects of E- and l-Type Prostaglandins on Human Platelet and Polymorphonuclear Cell Function

K. Schrör, G. Hecker, 1986 .

Enantioselective synthesis of inositols as intermediates for the preparation of deoxy-inositol phosphates from D-galactose

A. Loupy, E. Bischoff, D. Dubreuil, 1995 .

Elevation of circulating NO: its effects on hemodynamics and vascular smooth muscle cell proliferation in rats.

S. Wohlfeil, D. Denzer, G. Hecker, 1995, Agents and actions. Supplements.

Nerve-growth-factor-treated and v-src-expressing PC 12 cells: a model for neuronal differentiation.

D. Lewis, C. Jelsema, D. Rausch, 1991, Biochemical Society transactions.

Physiological targets of superoxide anion and hydrogen peroxide in reperfusion injury.

R. Busse, B. Brüne, V. Ullrich, 1989, Free radical research communications.

Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206.

K. Schrör, P. Ney, G. Hecker, 1987, Progress in clinical and biological research.

Potent inhibition of superoxide anion generation by PGE1 and the PGE1 analogue OP-1206 in human PMN's--unrelated to its antiplatelet PGI2-like activity.

K. Schrör, G. Hecker, 1987, VASA. Supplementum.

The Significance of the Peroxide Tone in the Arachidonic Acid Cascade

V. Ullrich, G. Hecker, M. Schatz-Munding, 1993 .